Skip to content
CancerIndex

Loading the knowledge graph…

A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis — knowledge graph · CancerIndex